Monday, 23 December 2019

Allergan's acute migraine treatment wins U.S. FDA approval

The U.S. Food and Drug Administration said on Monday it had approved Allergan Plc's drug for treating acute migraine in adults.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)